Home > Boards > US Listed > Medical - Drugs >


Add ALPMY Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/24/2016 9:56:49 AM - Followers: 7 - Board type: Free - Posts Today: 0

Astellas Pharma Inc., to fulfill its business philosophy to "Contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products," is actively engaged in business as an R&D-driven global pharmaceutical company.

2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan

Tel. +81-3-3244-3000




103,000 milion yen (March 2012)

Representative Director

Yoshihiko Hatanaka (President and Chief Executive Officer)


17,085 (Consolidated basis, March 2012)

Business Description

Manufacturing, marketing and import/export of pharmaceuticals.

The Astellas Group’s business philosophy has three elements — raison d'être, mission and beliefs. This business philosophy expresses the company’s of aiming to contribute to the health of people around the world through the provision of highly effective and trustworthy pharmaceuticals, while continuously increasing the Company's enterprise value.
Raison D'être
Contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products

To go beyond all others in exploring and tapping the potential of the life sciences.
To continue tackling new challenges and creating innovative pharmaceutical products.
To deliver quality products along with accurate information and retain solid credibility among customers.
To support healthy living for people around the world.
To continue shining on the global pharmaceutical field.

Sustainable enhancement of enterprise value

Astellas will seek to enhance its enterprise value in a sustainable manner.
Astellas will seek to be the company of choice among all its stakeholders, including its customers, shareholders, employees, and the global community.
Astellas will strive to gain the trust of all stakeholders and thereby enhance its enterprise value.

Interaction between astellas and its stakeholders

Our “beliefs” provide the code of conduct we prize at all times. Astellas will always be a group of people who act upon these beliefs.

High Sense of Ethics
We will always manage our business with the highest sense of ethics.
Customer Focus
We will always seek to understand customer needs and our focus will always be on achieving customer satisfaction.
We will not be complacent and will always seek to innovate to create new value.
Competitive Focus
Our eyes will always be directed to the outside world, and we will continue to create better value faster.

Astellas promises to perform its obligations toward all stakeholders by acting ethically and seeking to actively disclose information.
Main Text end
Local Navigation

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ALPMY News: Securities Registration (ads, Immediate) (f-6ef) 12/21/2017 04:17:42 PM
ALPMY News: Post-effective Amendment to a Previously Filed F-6. (f-6 Pos) 09/29/2017 01:03:05 PM
ALPMY News: Ocata Therapeutics Almost Doubled in November -- Here's Why 12/04/2015 04:03:03 PM
ALPMY News: Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen 11/25/2015 09:04:03 AM
ALPMY News: 3 Value Stocks Near 52-Week Lows Worth Buying 11/23/2015 10:07:10 AM
#18   You have got to be kidding. The interest Scottoo898 02/24/16 09:56:48 AM
#17   It's good to see OCAT/ACTC interest here. Astellas rdfdr1 02/23/16 10:24:00 AM
#16   They should really consider moving exchange to NASDAQ Lutfiyah holdings 02/22/16 08:35:11 PM
#15   Dr Lanza is now heading the global regenerative feedmyback 02/22/16 07:52:53 PM
#14   rdfdr1 previous post was for you smokey 02/11/16 03:34:58 PM
#13   Sure you did! smokey 02/11/16 03:28:56 PM
#12   Does the Astellas ADR pay dividends? Wouldn't it kyrie717 01/01/16 05:50:40 PM
#11   I just sold OCAT and put it all rdfdr1 12/03/15 12:01:36 PM
#10   Welcome to Astellas Lutfiyah holdings 11/15/15 08:35:44 AM
#9   Sorry, anyone know what Astellas Pharma, Inc (ALPMY) Sam0 06/02/15 09:42:31 AM
#8   Surf1944 how are you, tried to send you Harry Wickey 02/06/14 01:30:33 PM
#7   competion is severe in lucrative market mlkrborn 12/14/13 10:58:20 AM
#6   8:15AM Astellas Pharma reports positive topline phase 3 surf1944 09/30/13 09:49:41 AM
#5   yes it is: Astellas Announces FDA Approval of johnsyn 07/20/13 08:10:02 AM
#4   This is huge news jtrenee89 07/19/13 11:17:31 PM
#3   Medivation, Astellas Begin Mid-stage Study Of Enzalutamide - johnsyn 06/26/13 07:45:51 AM
#2   http://www.nasdaq.com/press-release/dr-helen-fisher-to-speak-at-astellas-present johnsyn 06/25/13 09:38:20 AM
#1   8:18 AM Cytokinetics (CYTK +9.8%) grants Astellas (ALPMF.PK) johnsyn 06/25/13 09:35:34 AM
Consent Preferences